Cargando…

Magnetic Resonance Imaging in Multiple Sclerosis – Patients' Experiences, Information Interests and Responses to an Education Programme

BACKGROUND: Magnetic resonance imaging (MRI) is a key diagnostic and monitoring tool in multiple sclerosis (MS) management. However, many scientific uncertainties, especially concerning correlates to impairment and prognosis remain. Little is known about MS patients' experiences, knowledge, att...

Descripción completa

Detalles Bibliográficos
Autores principales:	Brand, Judith, Köpke, Sascha, Kasper, Jürgen, Rahn, Anne, Backhus, Imke, Poettgen, Jana, Stellmann, Jan-Patrick, Siemonsen, Susanne, Heesen, Christoph
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4240649/ https://www.ncbi.nlm.nih.gov/pubmed/25415501 http://dx.doi.org/10.1371/journal.pone.0113252

Ejemplares similares

A new graphical format to communicate treatment effects to patients—A web‐based randomized controlled trial
por: Kasper, Jürgen, et al.
Publicado: (2016)

Applying the theory of planned behaviour to multiple sclerosis patients’ decisions on disease modifying therapy – questionnaire concept and validation
por: Kasper, Jürgen, et al.
Publicado: (2012)

Comprehension of confidence intervals - development and piloting of patient information materials for people with multiple sclerosis: qualitative study and pilot randomised controlled trial
por: Rahn, Anne C., et al.
Publicado: (2016)

Evaluator-blinded trial evaluating nurse-led immunotherapy DEcision Coaching In persons with relapsing-remitting Multiple Sclerosis (DECIMS) and accompanying process evaluation: study protocol for a cluster randomised controlled trial
por: Rahn, Anne Christin, et al.
Publicado: (2015)

Prognostic Risk Estimates of Patients with Multiple Sclerosis and Their Physicians: Comparison to an Online Analytical Risk Counseling Tool
por: Heesen, Christoph, et al.
Publicado: (2013)

Risk Knowledge in Relapsing Multiple Sclerosis (RIKNO 1.0) - Development of an Outcome Instrument for Educational Interventions
por: Heesen, C., et al.
Publicado: (2015)

T1w dark blood imaging improves detection of contrast enhancing lesions in multiple sclerosis
por: Thaler, Christian, et al.
Publicado: (2017)

Study protocol for a randomised controlled trial of a web-based behavioural lifestyle programme for emPOWERment in early Multiple Sclerosis (POWER@MS1)
por: Krause, Nicole, et al.
Publicado: (2021)

Assessing the effect of an evidence-based patient online educational tool for people with multiple sclerosis called UMIMS—understanding magnetic resonance imaging in multiple sclerosis: study protocol for a double-blind, randomized controlled trial
por: Schiffmann, Insa, et al.
Publicado: (2020)

Impairment and restrictions in possibly benign multiple sclerosis
por: Schaefer, Laura Melanie, et al.
Publicado: (2019)

T1- Thresholds in Black Holes Increase Clinical-Radiological Correlation in Multiple Sclerosis Patients
por: Thaler, Christian, et al.
Publicado: (2015)

Short-term MRI measurements as predictors of EDSS progression in relapsing-remitting multiple sclerosis: grey matter atrophy but not lesions are predictive in a real-life setting
por: von Gumberz, Johanna, et al.
Publicado: (2016)

Evaluation of an interactive web-based programme on relapse management for people with multiple sclerosis (POWER@MS2): study protocol for a process evaluation accompanying a randomised controlled trial
por: Wenzel, Lisa, et al.
Publicado: (2021)

Heterogeneity of Multiple Sclerosis Lesions in Multislice Myelin Water Imaging
por: Faizy, Tobias Djamsched, et al.
Publicado: (2016)

Increased Perfusion in Normal Appearing White Matter in High Inflammatory Multiple Sclerosis Patients
por: Bester, Maxim, et al.
Publicado: (2015)

Correction: Increased Perfusion in Normal Appearing White Matter in High Inflammatory Multiple Sclerosis Patients
por: Bester, Maxim, et al.
Publicado: (2015)

Regression to the Mean and Predictors of MRI Disease Activity in RRMS Placebo Cohorts - Is There a Place for Baseline-to-Treatment Studies in MS?
por: Stellmann, Jan-Patrick, et al.
Publicado: (2015)

Cognitive performance shows domain specific associations with regional cortical thickness in multiple sclerosis
por: Stellmann, Jan-Patrick, et al.
Publicado: (2021)

An interactive web-based programme on relapse management for people with multiple sclerosis (POWER@MS2) - development, feasibility, and pilot testing of a complex intervention
por: Wenzel, Lisa, et al.
Publicado: (2022)

Impact of a multimedia website with patient experiences of multiple sclerosis (PExMS) on immunotherapy decision-making: study protocol for a pilot randomised controlled trial in a mixed-methods design
por: Barabasch, Anna, et al.
Publicado: (2021)

Patient education for people with multiple sclerosis-associated fatigue: A systematic review
por: Wendebourg, Maria Janina, et al.
Publicado: (2017)

Reliability of cortical lesion detection on double inversion recovery MRI applying the MAGNIMS-Criteria in multiple sclerosis patients within a 16-months period
por: Faizy, Tobias Djamsched, et al.
Publicado: (2017)

Understanding Magnetic Resonance Imaging in Multiple Sclerosis (UMIMS): Development and Piloting of an Online Education Program About Magnetic Resonance Imaging for People With Multiple Sclerosis
por: Freund, Magalie, et al.
Publicado: (2022)

Risk knowledge of people with relapsing-remitting multiple sclerosis – Results of an international survey
por: Giordano, Andrea, et al.
Publicado: (2018)

Development and evaluation of an interactive web-based decision-making programme on relapse management for people with multiple sclerosis (POWER@MS2)—study protocol for a randomised controlled trial
por: Rahn, Anne Christin, et al.
Publicado: (2021)

Pattern of gray matter volumes related to retinal thickness and its association with cognitive function in relapsing–remitting MS
por: Stellmann, Jan‐Patrick, et al.
Publicado: (2016)

Correction to: Development and evaluation of an interactive web-based decision-making programme on relapse management for people with multiple sclerosis (POWER@MS2)—study protocol for a randomised controlled trial
por: Rahn, Anne Christin, et al.
Publicado: (2021)

MAPPIN'SDM – The Multifocal Approach to Sharing in Shared Decision Making
por: Kasper, Jürgen, et al.
Publicado: (2012)

Correction: MAPPIN'SDM – The Multifocal Approach to Sharing in Shared Decision Making
por: Kasper, Jürgen, et al.
Publicado: (2012)

Patients' and Observers' Perceptions of Involvement Differ. Validation Study on Inter-Relating Measures for Shared Decision Making
por: Kasper, Jürgen, et al.
Publicado: (2011)

Why not? – Communicating stochastic information by use of unsorted frequency pictograms – a randomised controlled trial
por: Kasper, Jürgen, et al.
Publicado: (2011)

Smartphone Accelerometry: A Smart and Reliable Measurement of Real-Life Physical Activity in Multiple Sclerosis and Healthy Individuals
por: Zhai, Yuyang, et al.
Publicado: (2020)

Reduced rich-club connectivity is related to disability in primary progressive MS
por: Stellmann, Jan-Patrick, et al.
Publicado: (2017)

Immunotherapy for people with clinically isolated syndrome or relapsing-remitting multiple sclerosis: treatment response by demographic, clinical, and biomarker subgroups (PROMISE)—a systematic review protocol
por: Lehnert, Thomas, et al.
Publicado: (2022)

‘That would have been the perfect thing after diagnosis’: development of a digital lifestyle management application in multiple sclerosis
por: Krause, Nicole, et al.
Publicado: (2022)

Dietary Interventions in Multiple Sclerosis: Development and Pilot-Testing of an Evidence Based Patient Education Program
por: Riemann-Lorenz, Karin, et al.
Publicado: (2016)

T1 Relaxation Times in the Cortex and Thalamus Are Associated With Working Memory and Information Processing Speed in Patients With Multiple Sclerosis
por: Thaler, Christian, et al.
Publicado: (2021)

Reasons for delayed admission after stroke: results of a qualitative and quantitative survey
por: Alegiani, Anna Christina, et al.
Publicado: (2019)

Quality of Stroke Patient Information Applied in Randomized Controlled Trials—Literature Review
por: Alegiani, Anna C., et al.
Publicado: (2020)

aHSCT is superior to alemtuzumab in maintaining NEDA and improving cognition in multiple sclerosis
por: Häußler, Vivien, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_5fir9lnmoqd9o3dnu3hgne0a0j